Board logo

subject: Toolkit for Diabetes MSL Programs [print this page]


Toolkit for Diabetes MSL Programs
Toolkit for Diabetes MSL Programs

Build a world-class diabetes medical science liaison (MSL) program

Today's MSLs are key strategic drivers for diabetes products' and overall company success. Currently, approximately 246 million people worldwide have diabetes; this number is expected to increase to 380 million by 2025, according to the International Diabetes Foundation. Such staggering figures solidify diabetes' position as a primary therapeutic area. They also indicate the value of medical science liaisons who are building relationships within the diabetes medical community.

Perhaps your company plans to enter a new market or maybe your diabetes MSL team needs an upgrade. In either case, The Toolkit for Diabetes MSL Programs provides clear, easy-to-access guidance on all aspects of diabetes MSL program management. The research focuses on these core areas:

MSL structure and staffing

MSL budgets

MSL responsibilities and activities metrics

KOL relationships and segmentation criteria

MSL qualifications and experience levels

KOL compensation

CEI has integrated its leading research in MSLs and thought leader management with a growing expertise in therapeutic areas to create a highly customized, data-driven report. You won't find this information anywhere else! Use The Toolkit for Diabetes MSL Programs to strengthen your diabetes MSL team's structure and operations.

Companies Included in Report

Amgen

Bayer Schering Pharma

Bristol-Myers Squibb

Eli Lilly

Merck & Co.

Novartis

Novo Nordisk

Pfizer

Sanofi-Aventis

Takeda

The report's five chapters contain these metrics:

Chapter 1: Structures and Staffing

Average age of formal programs

Total MSL FTEs - companywide

Number of MSLs per diabetes program team

MSL programs' organizational structures

MSL team alignment

Executive oversight of MSL programs

MSL department reporting relationships

Chapter 2: MSL Functions and Communications

MSL teams' involvement in the product lifecycle

Number of sales representatives per company

Ratio of sales representatives to MSLs per company

Number of brands supported per each MSL

Frequency of MSL communications via e-mail, face-to-face visits and telephone.

MSLs' time dedicated to:

Talking to doctors in the field

Performing educational activities

Researching clinical findings

Speaking opportunities

Providing information to managed care organizations

Chapter 3: Targeting Diabetes Opinion Leader Segments

Number of KOL Relationships per MSL

Percentage of KOL relationships - for specialists, primary care providers, and allied health professionals

Opinion leader selection factors

Segmentation criteria for the endocrinology therapeutic area

Profiles for thought leaders in Tiers 1 through 5

Minimum and maximum consulting hourly rates for Type 1 and Type 2 diabetes thought leaders - broken down by company size and by provider category

Average speaker fees for Type 1 and Type 2 diabetes thought leaders - broken down by company size and provider category

Average advisory panel fees for Type 1 and Type 2 diabetes thought leaders - broken down by company size and by provider category

Average author fees for Type 1 and Type 2 diabetes thought leaders - broken down by company size and by provider category

For more information kindly visit

http://www.bharatbook.com/detail.asp?id=100605&rt=Toolkit-for-Diabetes-MSL-Programs.html

OR Contact us at

Bharat Book Bureau

207, Hermes Atrium, Sector 11, CBD Belapur, Navi Mumbai - 400 614, India.

Phone : +91 22 2757 8668 / 2757 9438

Fax : +91 22 2757 9131

E-mail : info@bharatbook.com

Website : www.bharatbook.com




welcome to loan (http://www.yloan.com/) Powered by Discuz! 5.5.0